Primary Endpoint Results of NRG CC003: Phase IIR/111 Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC) Other Scholarly Work

Gondi, V, Pugh, S, Mehta, MP et al. (2023). Primary Endpoint Results of NRG CC003: Phase IIR/111 Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC) . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 117(4), E3-E3.

International Collaboration

cited authors

  • Gondi, V; Pugh, S; Mehta, MP; Wefel, JS; Tome, WA; Sun, A; Videtic, GM; Lok, BH; Yoon, HA; Heinzerling, JH; DeNittis, AS; McGarry, RC; Devisetty, K; Kundapur, V; Wu, AJ; Paulus, R; Kachnic, LA

authors

publication date

  • November 15, 2023

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • CA, San Diego

publisher

  • ELSEVIER SCIENCE INC

start page

  • E3

end page

  • E3

volume

  • 117

issue

  • 4